Ault Milton C III 的 Form 4/A 修正申報
修正Alzamend Neuro, Inc.（ALZN），2021/7/15 申報
- 申報編號
- 0001214659-21-007541
- 申報時間
- 2021/7/15
- 交易日
- 2021/7/12-7/14
- 申報延遲
- 3 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2021/7/14
這份申報列了 3 筆非衍生性交易。公開市場買進合計 $8.91 萬。交易後 3 天申報。
這份修正申報取代了 0001214659-21-007504（2021/7/14 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ault Milton C IIICIK 0001212502 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.1496. The range of purchase prices on the transaction date was $5.92 to $6.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
- F3
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.2633. The range of purchase prices on the transaction date was $6.19 to $6.32 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The original Form 4 filed on July 14, 2021, is amended by this Form 4 amendment to correct an error in the amount of shares from "5,000" to "5,500".
- F5
The original Form 4 filed on July 14, 2021, is amended by this Form 4 amendment to correct an error in the Price from "$6.7374" to "6.1249". The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.1249. The range of purchase prices on the transaction date was $5.86 to $6.75 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The original Form 4 filed on July 14, 2021, is amended by this Form 4 amendment to correct an error in the amount of shares from "5,320,055" to "5,320,555".
- F7
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- F8
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.